glp 1 plus insulin Glucagon-like peptide-1 Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic

It is prescribed to patients with diabetes

Explore glp-1 medications versus surgery at JourneyLite and understand how GLP-1's mimic hormone functions, managing weight loss effectively.

A recent composition for the Obesity Medicine Association titled "A New Path Forward" highlights struggles people living with obesity face, and has been viewed over 4,000 times

Background/Purpose: Obesity significantly increases cardiovascular morbidity and mortality in rheumatoid arthritis (RA), yet effective strategies for managing obesity-related risks in this population remain limited

Three months after stopping a GLP-1, 40% of patients had further improved their HbA1c compared to when they discontinued the GLP-1, 48% kept some of their improvement, and just 12% had a worse HbA1c compared to their pre-GLP-1 level.